Life Insurance for Melanoma: Why A Diagnosis Isn’t Always A Decline

A melanoma diagnosis doesn’t automatically mean a declined case, you can still get your client Standard, or even Preferred life insurance rates.

Skin cancer is the most common cancer in the United States, with a 1 in 5 lifetime risk, but the two most common types, Basal Cell and Squamous Cell carcinomas, are superficial and treatable. Remove it, keep up with regular skin exams, and in most cases, you’ll still be insurable at Preferred rates.

What Makes Melanoma More Dangerous than Other Skin Cancers?

Malignant Melanoma is a different animal. It results from a genetic mutation of skin cells and is potentially lethal. It spreads aggressively and carries the metastatic potential to enter the bloodstream and travel to other organs. That’s what makes it very dangerous.

Why Does UV Exposure and Tanning Bed History Matter for Underwriting?

If you or any of your clients have ever used a tanning bed, an annual dermatology skin check is essential. Ultraviolet light, whether from the sun or a tanning bed, significantly increases skin cancer risk. No one fully understands what triggers the mutation, but protection from UV exposure is clearly preventative. Dermatologists recommend SPF 30 as a baseline.

Here’s some generational context worth knowing: Baby Boomers did not grow up with sunscreen. Quite the opposite. TV ads were pushing Hawaiian Tropic and Bain de Soleil, promising the deepest, darkest tan possible. That history matters underwriting-wise today.

How Does Melanoma Staging Affect Underwriting Classification?

The encouraging news is that improved screening and early detection are identifying more melanoma cases at very early stages – Stage 0 and Stage 1. These early-stage melanomas are considered non-invasive to minimally invasive, and they’re often eligible for Standard underwriting classifications. In some cases, we’ve successfully negotiated early-stage melanoma cases into a Preferred risk category, depending on pathology details and follow-up history. That’s a real win for clients who assume a cancer diagnosis automatically means a declined or rated policy.

It’s important to note that the risk profile changes dramatically as staging advances to Stage 2 or beyond, so timing and documentation matter enormously.

How is Emerging Cancer Research Changing Underwriting Outcomes?

The same genetic mutations that make melanoma dangerous also make it more susceptible to some of the most promising new cancer therapies being researched today. Our SPG Life & Annuity office in Rockville, MD sits between the National Institutes of Health and the National Cancer Institute. The research coming out of that corridor is exciting and suggests that Stage IV melanomas are being cured.

Life insurance and reinsurance companies are historically slow to update their underwriting manuals since actuarial studies take years to compile. But by staying current on emerging therapies and treatment outcomes, the SPG Life & Annuity underwriting team is uniquely positioned to negotiate the best possible rating class for your cancer survivor cases. That’s not a small thing. That’s the difference between a client getting covered and a client walking away uninsured.

What Does Standard-Class Underwriting Look Like for Early-Stage Melanoma?

A Stage 1A diagnosis with clean surgical margins and consistent follow-up can be enough to negotiate Standard coverage. Here’s how that played out for a real SPG Life & Annuity client.

Mr. G, a Baby Boomer male, age 65, had a routine dermatology checkup in December 2023 where a single skin lesion was shaved for biopsy. It was discovered to be Malignant Melanoma at Breslow (a measurement of melanoma depth) thickness level .5mm. It was diagnosed as Superficial Spreading Melanoma at Stage 1A. He had secondary surgery removal (wide excision) of the cancer site with margins all “clean” and free of any cancer. Six months later, May 2024, we negotiated STANDARD life insurance coverage for Mr. G.

Can a Melanoma History Still Earn a Preferred Rate?

With enough follow-up history behind a client, the answer can be yes. Take a look at how it worked out for another of our clients.

Mr. B, also a Baby Boomer male, age 69, has had routine annual dermatology checkups for the past 11 years after a Squamous Cell skin cancer removal from his right shoulder. In 2019 a small mole looked suspicious to the dermatologist, and a shave biopsy was sent for pathology. The report came back as a Malignant Melanoma Stage 1. A wide excision was performed (deeper and wider tissue removal than the shave) with the final pathology report revealing no further cancer cells being found, and all surgical margins “clean”.  With Mr. B’s regular annual follow-up care and his Stage 1 Melanoma diagnosis, this case was negotiated to Preferred class for permanent coverage allowing for lifestyle and health style credits.

Don’t assume a melanoma history means a declined case. With the right documentation, the right timing, and a team that does the necessary work, your clients have more options than they think.

Cases like these come down to documentation, timing, and a willingness to make the case directly to underwriters — not guesswork. That’s the kind of work SPG Life & Annuity’s underwriting team does: reviewing the medical history, building the fact pattern, and presenting it to carriers so your clients get considered on the full picture, not just a diagnosis code.

Have a melanoma cancer survivor case you’re not sure how to place? Connect with the SPG Life & Annuity underwriting team and get a second look before you rule anything out.

SPG Life & Annuity is the life insurance and annuity distribution platform of Specialty Program Group, giving advisors access to national carrier relationships, advanced underwriting, and case design support.